Skip to main content
. Author manuscript; available in PMC: 2016 Apr 12.
Published in final edited form as: J Med Chem. 2016 Jan 29;59(3):1207–1216. doi: 10.1021/acs.jmedchem.5b01910

Figure 2.

Figure 2

Drug binding mode of the A/M2-S31N mutant. (a) Solution NMR structure of A/M2-S31N bound with the isoxazole inhibitor M2WJ332 (4) (PDB: 2LY0). (b) Representation of drug–protein interactions